Finding accredited CPD
Melanoma is an important public health problem in Australia, and its incidence and treatment costs are rising, particularly for advanced stage disease. The estimated lifetime risk of at least one melanoma diagnosis in Australia is 6.7% (one in fifteen).
Primary care practitioners diagnose and manage the vast majority of keratinocyte cancers in Australia (in contrast to other countries), but little has been published on how cutaneous melanoma is first diagnosed and which practitioners make the diagnosis.
This MJA research study shares more.
Author: Nirmala Pandeya, Catherine M Olsen, Maja M Shalit, Jean Claude Dusingize, Rachel E Neale and David C Whiteman
Article Type: Research
You have to log in to see the content of this module.
Provided by
Accredited by
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)